BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17305016)

  • 21. Co-opting of ClinicalTrials.gov by patient-funded studies.
    Wagner DE; Turner L; Panoskaltsis-Mortari A; Weiss DJ; Ikonomou L
    Lancet Respir Med; 2018 Aug; 6(8):579-581. PubMed ID: 29934051
    [No Abstract]   [Full Text] [Related]  

  • 22. NCI's transition plan for participants in women's health trial.
    Oncology (Williston Park); 1988 Dec; 2(12):36. PubMed ID: 3079290
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD; Greenwald P
    Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
    [No Abstract]   [Full Text] [Related]  

  • 24. Peer review and the NCI's clinical alert on node-negative breast cancer.
    Feinberg BA
    JAMA; 1989 Feb; 261(5):695-6. PubMed ID: 2642980
    [No Abstract]   [Full Text] [Related]  

  • 25. An FDA oncology view of juvenile animal studies in support of initial pediatric trials for anticancer drugs.
    Leighton JK; Saber H; Reaman G; Pazdur R
    Regul Toxicol Pharmacol; 2016 Aug; 79():142-143. PubMed ID: 26952647
    [No Abstract]   [Full Text] [Related]  

  • 26. NIH and FDA seek to increase oversight of gene therapy research.
    J Investig Med; 2000 May; 48(3):169-71. PubMed ID: 10822896
    [No Abstract]   [Full Text] [Related]  

  • 27. NCI's coping with cancer information and education program--evolution, planning, and implementation.
    Blumberg BD
    Prog Clin Biol Res; 1982; 83():83-90. PubMed ID: 7089015
    [No Abstract]   [Full Text] [Related]  

  • 28. Report of the Cancer Chemotherapy Collaborative Program Review Committee: the Richardson report. June 1966, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Cancer Treat Rep; 1984 Jan; 68(1):343-56. PubMed ID: 6692435
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of the national cancer program and proposed reforms.
    Epstein SS
    Int J Health Serv; 1993; 23(1):15-44. PubMed ID: 8425784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the FDA in cancer therapy research.
    Young RS
    Semin Oncol; 1981 Dec; 8(4):447-52. PubMed ID: 7323818
    [No Abstract]   [Full Text] [Related]  

  • 31. The National Cancer Institute: cancer drug discovery and development program.
    Grever MR; Schepartz SA; Chabner BA
    Semin Oncol; 1992 Dec; 19(6):622-38. PubMed ID: 1462164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NIH improves its record on women in trials.
    Birmingham K
    Nat Med; 2000 Jun; 6(6):612. PubMed ID: 10835658
    [No Abstract]   [Full Text] [Related]  

  • 33. Panel discussion 2.
    Lan G; Lindborg S; Neaton J
    Clin Trials; 2012 Dec; 9(6):736-40. PubMed ID: 23250944
    [No Abstract]   [Full Text] [Related]  

  • 34. Pediatric drug research--the road less traveled.
    Holdsworth MT
    Ann Pharmacother; 2003 Apr; 37(4):586-91. PubMed ID: 12659620
    [No Abstract]   [Full Text] [Related]  

  • 35. Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute.
    Christian MC; Pluda JM; Ho PT; Arbuck SG; Murgo AJ; Sausville EA
    Semin Oncol; 1997 Apr; 24(2):219-40. PubMed ID: 9129691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National cancer institute perspectives.
    Wong RS; Brechbiel MW
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S96-9. PubMed ID: 16979449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant DNA Advisory Committee. U.S. Department of Health and Human Services, Public Health Service, National Institute of Health.
    Hum Gene Ther; 2001 Nov; 12(17):2129-51. PubMed ID: 11747602
    [No Abstract]   [Full Text] [Related]  

  • 38. Academically led clinical trials: challenges and opportunities.
    Turajlic S; Larkin J; Swanton C
    Ann Oncol; 2015 Oct; 26(10):2010-1. PubMed ID: 26240217
    [No Abstract]   [Full Text] [Related]  

  • 39. A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies.
    Deverka PA; Bangs R; Kreizenbeck K; Delaney DM; Hershman DL; Blanke CD; Ramsey SD
    J Natl Cancer Inst; 2018 Jun; 110(6):553-559. PubMed ID: 29684151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials. Ventilator study gets second wind.
    Malakoff D
    Science; 2003 Jul; 301(5630):149. PubMed ID: 12855776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.